Maria Colavincenzo

Clinical severity does not reliably predict quality of life in women with alopecia areata, telogen effluvium, or androgenic alopecia

Erika E. Reid, Ann Cameron Haley, Judy H. Borovicka et al. · Journal of the American Academy of Dermatology · 2011 · 130 citations

Predict Quality, Alopecia Areata, Dermatology +3

Phase 2 randomized, dose-ranging trial of CTP-543, a selective Janus Kinase inhibitor, in moderate-to-severe alopecia areata

Brett King, Natasha Atanaskova Mesinkovska, Paradi Mirmirani et al. · Journal of the American Academy of Dermatology · 2022 · 75 citations · Full text

A phase 2a randomized vehicle-controlled multi-center study of the safety and efficacy of delgocitinib in subjects with moderate-to-severe alopecia areata

Daniela Mikhaylov, Jacob W. Glickman, Ester Del Duca et al. · Archives of Dermatological Research · 2022 · 36 citations

Moderate-to-severe Alopecia Areata, Clinical Dermatology, Skin Pharmacology +4

A Point-of-Care, Real-Time Artificial Intelligence System to Support Clinician Diagnosis of a Wide Range of Skin Diseases

Brittany Dulmage, Kyle Tegtmeyer, Michael Zhang et al. · Journal of Investigative Dermatology · 2020 · 31 citations

Artificial Intelligence, Disease Diagnosis, Engineering +13

A Qualitative, Cross-Sectional Study of Positive and Negative Comments of Residency Programs Across 9 Medical and Surgical Specialties

Brittany Dulmage, Lisa Akintilo, Leah J. Welty et al. · The American Journal of Medicine · 2018 · 15 citations

Nursing, Family Medicine, Surgical Specialties +7